We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $8.34B
1-Year Est. Return 165.53%
This Fund
S&P 500
This Quarter Est. Return
+77.9%
1 Year Est. Return
+165.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.34B
AUM Growth
+$2.35B
Cap. Flow
-$42M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.57%
Holding
644
New
20
Increased
132
Reduced
424
Closed
57

Top Sells

Rank Stock Value
1
TSEM icon
Tower Semiconductor
TSEM
+$220M
2
LITE icon
Lumentum
LITE
+$219M
3
TSLA icon
Tesla
TSLA
+$50.1M
4
CIEN icon
Ciena
CIEN
+$43.3M
5
MSFT icon
Microsoft
MSFT
+$42.6M

Sector Composition

Rank Sector Weight
1 Technology 66.11%
2 Communication Services 9.64%
3 Consumer Discretionary 8.42%
4 Industrials 4.35%
5 Healthcare 4.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDV icon
326
Indivior Pharmaceuticals
INDV
$4.12B
$109K ﹤0.01%
2,648
-156
-6% -$5.66K
FR icon
327
First Industrial Realty Trust
FR
$8.2B
$108K ﹤0.01%
1,763
-240
-12% -$14.9K
XENE icon
328
Xenon Pharmaceuticals
XENE
$5.79B
$106K ﹤0.01%
1,763
+28
+2% +$1.55K
CAI
329
Caris Life Sciences
CAI
$7.08B
$106K ﹤0.01%
5,970
-367
-6% -$6.57K
RHP icon
330
Ryman Hospitality Properties
RHP
$8.52B
$104K ﹤0.01%
812
-94
-10% -$10.4K
YUM icon
331
Yum! Brands
YUM
$41.1B
$102K ﹤0.01%
637
REXR icon
332
Rexford Industrial Realty
REXR
$8.2B
$99.9K ﹤0.01%
2,981
-598
-17% -$20.9K
DFTX
333
Definium Therapeutics
DFTX
$5.12B
$99.3K ﹤0.01%
2,111
-102
-5% -$2.52K
VCYT icon
334
Veracyte
VCYT
$3.42B
$98.8K ﹤0.01%
1,683
-92
-5% -$3.86K
SD icon
335
SandRidge Energy
SD
$531M
$98.8K ﹤0.01%
+7,211
New +$108K
PL icon
336
Planet Labs
PL
$6.59B
$97.6K ﹤0.01%
2,947
+1,161
+65% +$42.9K
STAG icon
337
STAG Industrial
STAG
$7.27B
$97.4K ﹤0.01%
2,560
-262
-9% -$10K
TXG icon
338
10x Genomics
TXG
$8.16B
$95.5K ﹤0.01%
2,492
-124
-5% -$3.25K
EWTX icon
339
Edgewise Therapeutics
EWTX
$4.68B
$92.3K ﹤0.01%
2,272
-106
-4% -$3.65K
SOC icon
340
Sable Offshore Corp
SOC
$909M
$92K ﹤0.01%
29,855
-11,075
-27% -$141K
TRNO icon
341
Terreno Realty
TRNO
$7.15B
$91.8K ﹤0.01%
1,417
-145
-9% -$9.48K
ACAD icon
342
Acadia Pharmaceuticals
ACAD
$4.83B
$91.3K ﹤0.01%
3,609
-190
-5% -$4.18K
HR icon
343
Healthcare Realty
HR
$6.55B
$89.6K ﹤0.01%
4,444
-605
-12% -$11.8K
TNGX icon
344
Tango Therapeutics
TNGX
$3.8B
$89.2K ﹤0.01%
2,852
-159
-5% -$3.93K
GPCR icon
345
Structure Therapeutics
GPCR
$3.38B
$88.6K ﹤0.01%
1,651
+151
+10% +$6.68K
DNLI icon
346
Denali Therapeutics
DNLI
$3.56B
$86.3K ﹤0.01%
3,357
+63
+2% +$1.29K
DLTR icon
347
Dollar Tree
DLTR
$24.7B
$84.7K ﹤0.01%
700
EPRT icon
348
Essential Properties Realty Trust
EPRT
$6.41B
$84.6K ﹤0.01%
2,835
-161
-5% -$5K
VNO icon
349
Vornado Realty Trust
VNO
$6.83B
$83.4K ﹤0.01%
2,122
-346
-14% -$11.2K
CRNX
350
DELISTED
Crinetics Pharmaceuticals
CRNX
$82.9K ﹤0.01%
2,216
+85
+4% +$3.16K

Similar funds

GF Fund Management's Q2 2026 Portfolio in Review

As of Q2 2026, GF Fund Management held 644 positions worth $8.34B, up 39% from $5.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

GF Fund Management's Q2 2026 filing shows 20 new, 132 increased, 424 reduced and 57 closed positions. Its largest new stake was INNIO N.V.: 4,970,000 shares worth $197M. The largest sale was Tower Semiconductor, an estimated $220M.

By sector, the portfolio is most concentrated in Technology at 66% of assets, up from 54% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q2 2026 buy was INNIO N.V.: 4,970,000 shares worth $197M.
  • GF Fund Management added most to Advanced Micro Devices in Q2 2026, an estimated $119M increase.
  • GF Fund Management's biggest Q2 2026 reduction was Tower Semiconductor, cutting an estimated $220M.
  • GF Fund Management fully exited Coherent in Q2 2026, selling an estimated $23.3M.
  • GF Fund Management's ten largest holdings make up 47% of its $8.34B portfolio in Q2 2026.
  • GF Fund Management opened 20 new positions and closed 57 in Q2 2026.
  • GF Fund Management's portfolio value rose 39% quarter-over-quarter to $8.34B.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.